Solara Active Pharma Sciences Ltd Nine Monthly Results

Gross Sales

1,010.75

989.49

1,063.19

907.52

1,172.67

Excise Duty

0

0

0

0

0

Net Sales

1,010.75

989.49

1,063.19

907.52

1,172.67

Other Operating Income

0

0

0

0

0

Other Income

2.37

3.67

17.87

13.95

18.99

Total Income

1,013.12

993.16

1,081.06

921.47

1,191.66

Total Expenditure

849.84

1,162.42

978.07

843.26

885.91

PBIDT

163.28

-169.26

102.99

78.21

305.75

Interest

85.69

74.42

68.1

53.81

59.65

PBDT

77.59

-243.68

34.89

24.4

246.1

Depreciation

74.95

78.08

84.74

84.5

81.22

Minority Interest Before NP

0

0

0

0

0

Tax

0

0

0.47

0

28.77

Deferred Tax

0

-10.25

-24.32

0

-28.63

Reported Profit After Tax

2.64

-311.51

-26

-60.1

164.74

Minority Interest After NP

0

0.54

-0.06

-0.07

-0.01

Net Profit after Minority Interest

2.64

-312.05

-25.94

-60.03

164.75

Extra-ordinary Items

0

-67.99

0

-2.18

0

Adjusted Profit After Extra-ordinary item

2.64

-244.06

-25.94

-57.85

164.75

EPS (Unit Curr.)

1.07

-81.54

-7.21

-16.71

53.43

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

40

Equity

40.25

36

36

35.94

35.9

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

16.15

-17.1

9.68

8.61

26.07

PBDTM(%)

7.67

-24.62

3.28

2.68

20.98

PATM(%)

0.26

-31.48

-2.44

-6.62

14.04